Search NLS News

The company’s autologous natural killer (NK) cell therapy candidate XNK04 will be evaluated in combination with an ADCC competent PD-L1 inhibitor in liver cancer under a research agreement with a global pharma company. The preclinical validation study aims to test the cell therapy candidate XNK04 alone and in combination with an antibody checkpoint inhibitor against […]

Through this agreement, Lundbeck will gain access to Alloy’s Antibody Discovery Services and it SeqImmune discovery module, which is a sequence-first workflow for early-on repertoire capture and generation of maximum initial diversity. Lundbeck has licensed Alloy’s ATX-Gx humanized transgenic mouse platform since 2020, and this partnership reflects a deepening of the relationship between the companies, […]

AlgoDx is the winner of the rising star category of Swecare Export Awards. The jury’s motivation “This year’s winner is an exciting company that developed a method for managing sepsis. Through a platform that uses artificial intelligence to advance diagnosis, you can both save lives and reduce healthcare costs. Using disruptive technology and evidence-based software, […]

Hanneke Later-Nijland is an attorney-at-law and a trained pharmacist from the Netherlands who recently launched The Genotype Network, a network for corporate and regulatory lawyers specialized in life sciences. Describe the purpose of the network? “The purpose is to add value, and more specifically to advance transactions in the life science space in every aspect, […]

Gedea Biotech has announces that the treatment of the first patients with its lead product, pHyph, a vaginal tablet for topical treatment, has begun. The open-labelled study is designed to confirm the safety and efficacy of pHyph in treating adult women with confirmed Vulvo Vaginal Candidiasis (VVC) and in restoring a beneficial vaginal microbiome to […]

Elicera Therapeutics has received approval from the Swedish Medical Products Agency (MPA) on its Clinical Trial Application (CTA) to evaluate its CAR T-cell therapy, ELC-301, in treatment of patients with B-cell lymphoma (CARMA-study), conditional on certain further validations of its GMP-process. Elicera is acting co-sponsor together with Uppsala university. “This is a major milestone for […]

In January 2023, the European Association for the Study of Obesity (EASO) and the Novo Nordisk Foundation (NNF) announced that they were establishing a new prize for an agenda-setting researcher within obesity, the Obesity Prize for Excellence. Their first recipient has now been announced. It is Ruth Loos, Professor, Novo Nordisk Foundation Center for Basic […]

Devyser receives the award for revolutionary solutions, extensive export investment and focus on correct diagnosis for each patient in the shortest possible time. Ulf Klangby, deputy CEO and one of the company’s founders, received the award from the Minister of Social Affairs and Public Health Jacob Forssmed at a ceremony in Stockholm. “We are incredibly […]

The Board of Directors of Umeå Biotech Incubator (UBI) has announced that CEO Jennie Ekbeck is leaving her post after eleven years. Since it was founded in 2003, UBI has established itself as one of Europe’s leading biotechnology incubators. Today it is both an incubator, where innovators receive help starting up and developing their companies, […]

The FDA’s Oncologic Drugs Advisory Committee (ODAC) has recognized a favorable benefit risk profile for AstraZeneca and MSD’s Lynparza plus abiraterone and prednisone or prednisolone for the treatment of adult patients with BRCA-mutated (BRCAm) metastatic castration-resistant prostate cancer (mCRPC) but it voted 11 to 1, with 1 abstaining, that the indication should be limited to patients […]